<?xml version="1.0" encoding="UTF-8"?>
<p>The anti‐viral agents of remdesivir, favipiravir and penciclovir can block the RNA‐dependent RNA polymerase (RdRp) of many RNA viruses, specially the influenza virus. Wang et al. determined the efficiency of these agents on infected Vero E6 cells with SARS‐CoV‐2 (Li &amp; De Clercq, 
 <xref rid="tbed13734-bib-0042" ref-type="ref">2020</xref>; Wang et al., 
 <xref rid="tbed13734-bib-0087" ref-type="ref">2020</xref>; Zhang, Lin, et al., 
 <xref rid="tbed13734-bib-0101" ref-type="ref">2020</xref>). The high concentrations of penciclovir (EC50 = 95.96 μM) and favipiravir (EC50 = 61.88 μM) were needed to decrease the viral infection, while remdesivir (EC50 = 0.77 μM) prevented the virus multiplication even at low concentrations.
</p>
